Bisphosphonate-associated osteonecrosis of the jaw-Reference-Cited by-同舟云学术

Bisphosphonate-associated osteonecrosis of the jaw

Published:2021-04 Issue:1 Volume:70 Page:
ISSN:2724-6329
Container-title:Minerva Dental and Oral Science
language:
Short-container-title:Minerva Dent Oral Sc

Author:

FERREIRA Jr Jr. Luiz H.,MENDONÇA Jr Jr. Kedson D.,CHAVES de SOUZA Jessica,SOARES dos REIS Danyella C.,do CARMO FALEIROS VELOSO GUEDES Cizelene,de SOUZA CASTRO FILICE Letícia,BRUZADELLI MACEDO Sérgio,SOARES ROCHA Flaviana

Publisher

Edizioni Minerva Medica

Subject

Otorhinolaryngology,Oral Surgery,Surgery

Link

https://www.minervamedica.it/pdf.php?cod=R18Y2021N01A0049

Reference43 articles.

1. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic

2. Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment

3. Bisphosphonates-induced osteonecrosis of the jaw - epidemiological, clinical and histopathological aspects;Mânea HC;Rom J Morphol Embryol,2018

4. Systematic Review: Bisphosphonates and Osteonecrosis of the Jaws

5. Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonate-Induced Orbital Cellulitis in a Patient With Suspected Parathyroid Carcinoma: A Case Report;Cureus;2024-07-01

2. Mitigating jaw osteonecrosis: bioactive glass and pericardial membrane combination in a rat model;Frontiers in Oncology;2024-05-10

3. Can jaw bone healed from chronic sclerosing osteomyelitis be considered healthy when planning dental implants? Case report with 20-year follow-up;Annals of Medicine & Surgery;2024-02-15

4. Management of Postmenopausal Osteoporosis by Moroccan General Practitioners: A Cross-Sectional Survey;Current Rheumatology Reviews;2024-02

5. Efficacy and risk of osteonecrosis of the jaw for pamidronate, zoledronic acid, and denosumab in comparison to alendronate in multiple myeloma patients;Baylor University Medical Center Proceedings;2024-01-08